Posted 21 June, 2021
Century Therapeutics, Inc. IPO completed
IPO completed detected for ticker Nasdaq:IPSC in a 424B4 filed on 21 June, 2021.
This is the initial public offering of shares of common stock of Century Therapeutics, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Century Therapeutics, Inc.
Health Care/Life Sciences • Biotechnology
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.Market Cap
$245M
View Company Details
$245M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.